3Bio Biologics is a next-generation biologics solutions partner specializing in high-performance development, analytical rigor, and global-scale biomanufacturing strategy. Built at the intersection of science, technology, and advanced CDMO collaboration, 3Bio is designed to help innovative biotech companies accelerate from concept to clinic with clarity, precision, and speed.

We combine deep scientific expertise with a networked approach to biomanufacturing, enabling clients to access the right capabilities, the right geography, and the right technical depth at every stage of their program. Our focus is simple: deliver smarter pathways for complex biologics—whether recombinant proteins, enzymes, phage-based therapeutics, or emerging biologic modalities.

At 3Bio, we believe excellence is not a fixed point but a continuous, data-driven process. Our team emphasizes Quality by Design, modern analytical frameworks, and strategic program architecture to de-risk development and strengthen long-term manufacturability.

3Bio Biologics is part of the global CDMO Network, aligning leading biomanufacturing partners across North America, Europe, and Asia into a single, neutral infrastructure designed to serve innovators with transparency, optionality, and world-class technical support.

Our mission is to elevate biologics development into a smarter, more connected, and more resilient ecosystem—one where companies can scale not just faster, but better.